LENSAR, Inc. (LNSR): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$26.02M
As of 2025-12-31
$14.90M
As of 2026-06-30
$67.21M2019-12-31: -$30.55M2020-12-31: $67.21M2021-12-31: $54.88M2022-12-31: $41.98M2023-12-31: $33.43M2024-12-31: $4.86M2025-12-31: -$26.02M-$26.02M
2019-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$26.02Mn/m2026-03-31, Balance as of period end
2024-12-31$4.86M-85.5%2026-03-31, Balance as of period end
2023-12-31$33.43M-20.4%2025-02-27, Balance as of period end
2022-12-31$41.98M-23.5%2024-03-04, Balance as of period end
2021-12-31$54.88M-18.3%2023-03-16, Balance as of period end
2020-12-31$67.21Mn/m2022-03-03, Balance as of period end
2019-12-31-$30.55Mn/a2021-03-12, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
LENSAR, Inc. (LNSR)2025-12-31-$26.02Mn/m
CVRx, Inc. (CVRX)2025-12-31$39.32M-44.7%
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$188.93M+18.8%
Apyx Medical Corp (APYX)2025-12-31$14.54M+2.3%
Carlsmed, Inc. (CARL)2025-12-31$98.87Mn/m
AVITA Medical, Inc. (RCEL)2025-12-31-$16.65Mn/m
Shoulder Innovations, Inc. (SI)2025-12-31$140.75Mn/m
TriSalus Life Sciences, Inc. (TLSI)2025-12-31-$33.86Mn/m
Sight Sciences, Inc. (SGHT)2025-12-31$63.94M-26.9%

Compare LNSR, CVRX, MHUAF, APYX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗